If mast cells in renal tumors exert similar functions, the Sanchez finding would suggest that obesity should be detrimental to anti-PD-1 outcomes in RCC patients – a controversial idea that we discuss further below. This evidence concerns the gene PDCD1 and obesity due to melanocortin 4 receptor deficiency.